SHL TELEMEDICINE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.75 CHF | -2.06% |
|
-2.06% | -31.65% |
| 18/04 | SHL Telemedicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 17/04 | Transcript : SHL Telemedicine Ltd., 2023 Earnings Call, Apr 17, 2024 |
| Sales 2024 * | 62M 56.62M 5.17B | Sales 2025 * | 75M 68.5M 6.25B | Capitalization | 85.12M 77.74M 7.1B |
|---|---|---|---|---|---|
| Net income 2024 * | -4M -3.65M -334M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 1.37 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.13 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 583 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.95% |
More Fundamentals
* Assessed data
More news
Latest transcript on SHL Telemedicine Ltd.
More press releases
| 1 day | -2.06% | ||
| 1 week | -2.06% | ||
| Current month | -12.84% | ||
| 1 month | -12.04% | ||
| 3 months | -15.18% | ||
| 6 months | -45.09% | ||
| Current year | -31.65% |
1 week
4.60
4.85
1 month
4.505.90
Current year
4.507.00
1 year
4.5011.50
3 years
4.5020.00
5 years
4.3220.00
10 years
4.3220.00
| Managers | Title | Age | Since |
|---|---|---|---|
Erez Nachtomy
CEO | Chief Executive Officer | 62 | 01/18/01 |
Amir Hai
DFI | Director of Finance/CFO | 58 | 01/22/01 |
Yossi Vadnagra
COO | Chief Operating Officer | - | 21/17/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shuky Abramowitz
BRD | Director/Board Member | 63 | 28/17/28 |
Yariv Alroy
CEO | Chief Executive Officer | 63 | 01/00/01 |
Dvora Kimhi
BRD | Director/Board Member | - | 10/18/10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 4.75 | -2.06% | 1,857 |
| 25/24/25 | 4.85 | 0.00% | 0 |
| 24/24/24 | 4.85 | 0.00% | 0 |
| 23/24/23 | 4.85 | +5.43% | 938 |
| 22/24/22 | 4.6 | -5.15% | 494 |
Delayed Quote Swiss Exchange, April 26, 2024 at 09:01 pm IST
More quotes
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHLâs platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Calendar
09/05/2024
- Extraordinary Shareholders Meeting
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.65% | 85.12M | |
| +40.45% | 2.68B | |
| +22.83% | 527M | |
| +42.77% | 467M | |
| -64.56% | 156M |
- Stock Market
- Equities
- SHLTN Stock
